Racial profiling in medical research

Editorial

R S Schwartz. N Engl J Med. 2001.

. 2001 May 3;344(18):1392-3.

doi: 10.1056/NEJM200105033441810.

No abstract available

Comment in

Race and responsiveness to drugs for heart failure.
Masoudi FA, Havranek EP. Masoudi FA, et al. N Engl J Med. 2001 Sep 6;345(10):767; author reply 767-8. N Engl J Med. 2001. PMID: 11547751 No abstract available.

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.
Exner DV, Dries DL, Domanski MJ, Cohn JN. Exner DV, et al. N Engl J Med. 2001 May 3;344(18):1351-7. doi: 10.1056/NEJM200105033441802. N Engl J Med. 2001. PMID: 11333991
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.
Yancy CW, Fowler MB, Colucci WS, Gilbert EM, Bristow MR, Cohn JN, Lukas MA, Young ST, Packer M; U.S. Carvedilol Heart Failure Study Group. Yancy CW, et al. N Engl J Med. 2001 May 3;344(18):1358-65. doi: 10.1056/NEJM200105033441803. N Engl J Med. 2001. PMID: 11333992 Clinical Trial.
Racial differences in the response to drugs--pointers to genetic differences.
Wood AJ. Wood AJ. N Engl J Med. 2001 May 3;344(18):1394-6. doi: 10.1056/NEJM200105033441811. N Engl J Med. 2001. PMID: 11336055 No abstract available.